EUCTR2017-002936-17-SE
Active, not recruiting
Phase 1
Treatment with intralipid in assisted fertilization
ivio Falun0 sites2,200 target enrollmentOctober 24, 2017
ConditionsInfertility conditions that required IVF treatment Male infertility Endometrosis PCOS uNEXPLAINED INFERTILITY Tubal damageTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
DrugsIntralipid
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Infertility conditions that required IVF treatment Male infertility Endometrosis PCOS uNEXPLAINED INFERTILITY Tubal damage
- Sponsor
- ivio Falun
- Enrollment
- 2200
- Status
- Active, not recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion \-Eligible for IVF tratment .Max female age 39years ,AMH\=\>1
- •NG/ML, BMI\<35, Ejaculated Viable Spermatozoa.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 2200
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range 0
Exclusion Criteria
- •Myoma\-Firoids ,uterine anomlies,Allergies against soya,peanuts,glycin
- •diseases requiring medications such as diabetes,Female age öve r39
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Artiificial oocyte activation for fertilization failure following ICSIInfertilityJPRN-UMIN000032038Hyogo College of Medicine, Department of Obstetrics and Gynecology200
Recruiting
Phase 1
Intrauterine administration of autologous PBMC in patients with RIF.infertile womanrepeated implantation failureJPRN-jRCTc050190121Mandai Masaki200
Recruiting
Not Applicable
Intrauterine administration of autologous peripheral blood mononuclear cells in patients with repeated implantation failure.patients with repeated implantation failureJPRN-UMIN000022434Kyoto University100
Not yet recruiting
Phase 3
A clinical trial to assess the benefits of a drug, intravenous lipid emulsion in patients presenting with pesticide (organophosphate) poisoningCTRI/2019/12/022335Department of Emergency Medicine All India Institute of Medical Sciences New Delhi
Completed
Not Applicable
Use of an Intra Uterine Balloon to Prevent Recurrent Adhesions (REpAIR)Adhesion; Uterus, InternalNCT03446755University Hospital, Ghent10